Address
Sigvion Capital
806 West Washington Street
Suite 204
Chicago, IL 60607
United States
Phone
Email
Website
Recent investment activity
KANDO id: 2419
Corporate information
Registration country
Relation
Renamed to
Funding rounds
Investment activity status
Not investing
Selected investments
Displaying 1 - 4 of 4| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Kereos Inc | Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. | N/A | |||
|
|
Logical Therapeutics Inc | An early stage biotechnology company | N/A | |||
|
|
Akebia Therapeutics Inc | Series B | ||||
|
|
Akebia Therapeutics Inc | Series A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Joshua Fairbank | [email protected] | |||
| Michael E Pape | [email protected] |